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OBJECTIVE: To set up regional assistant systems, inte-
grate health resources and advocate high-quality health
service, Department of Health in Taiwan promotes the
4th Health Network-New Era Health Care Program in
central of Taiwan. One of the major issues is to promote
public health education. We set up an educational
program to promote appropriate medication concept 
to the public and students in communities in central 
of Taiwan. METHODS: Supported by Department of
Health and conducted for one year, this was a prospec-
tive program consisting of training workshops for 
community pharmacists, developing and implementing
surveys, and public educational promotion. The major
issues of public educational promotions include appro-
priate use of medication, especially those about general
medication use, antimicrobial agents and being alert
against drug abuse. Even though 34 community pharma-
cists were recommended from four pharmacy associations
in central Taiwan and participated in the training work-
shops, only 8 pharmacists were qualiﬁed as instructor
pharmacists according to the results of questionnaire and
realistic demonstration after training and evaluating.
During 3 months, we held 13 promotions; 6 of them were
held in communities and 7 in schools. To evaluate the out-
comes of promotions, we conducted a pre- and post-
promotion survey via questionnaires. Questionnaires
included general information, medication information
resources and medication knowledge. RESULTS: A total
of 226 participates in communities were distributed with
115 post-promotion survey (51%) and of 475 partici-
pates in schools were distributed with 410 (86%) post-
promotion survey. The pre-promotion results showed
that 57.07% community participators and 77.48% 
students got medication information from more than 2
sources. After promotions, the results showed that med-
ication knowledge improved signiﬁcantly in schools and
community participators (p < 0.05). CONCLUSIONS:
We can ﬁnd out that it sure is a good opportunity for
pharmacists to contact the public through well-designed
promotion activities and beneﬁt the healthcare systems.
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OBJECTIVES: Anxiety disorders are among the most
common mental health conditions in the United States but
study of their impact on labor productivity has been
limited. The objective of this study was to estimate the
annual indirect costs due to anxiety disorders in the U.S.
population. METHODS: Retrospective analysis was con-
ducted of the 1999 Medical Expenditure Panel Survey
(MEPS). The MEPS provided data from a nationally 
representative sample of 24,618 respondents and their
medical care and health insurance providers and employ-
ers. Data extracted for this study included medical con-
ditions and employment information comprised of hourly
earnings, hours worked per week, and disability days.
Anxiety disorders were deﬁned using the current Diag-
nostic and Statistical Manual of Mental Disorders (DSM-
IV-TR) and were mapped to corresponding ICD-9-CM
codes and included anxiety and panic disorders, stress
disorders, obsessive compulsive disorder, and phobias.
Patients with an anxiety disorder who incurred absence
from work were identiﬁed using ICD-9-CM codes and
variables denoting disability days. Indirect costs were 
calculated for patients who missed workdays using the
human capital approach. Sample estimates were weighted
and projected to the population and 95% conﬁdence
limits were calculated using the Taylor expansion
method. RESULTS: As a percentage of the population,
the number of patients with an anxiety disorder who
missed workdays was low, at 0.20 percent (95% CL =
0.13 to 0.27). However, the associated indirect costs were
substantial, estimated at $2,981,633,568. Mean indirect
costs were $5347 per patient who missed workdays. Rel-
ative to the entire population, mean indirect costs per
person were $10.79. CONCLUSIONS: Although the
prevalence of anxiety disorders resulting in absenteeism
was found to be relatively low, the corresponding losses
in productivity were almost $3 billion. This suggests long-
term disability associated with these conditions and high-
lights the importance of early diagnosis and treatment to
minimize work loss.
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OBJECTIVES: To compare “homeopathic drugs” 
strategy (strategy H) with “psychotropic drugs” strategy
(strategy P) for treating anxiety disorders in France, 
in terms of effectiveness, satisfaction, and costs.
METHODS: Effectiveness, satisfaction, and economic
data were derived from a 3-month pragmatic prospective
study including 394 patients which were “male or 
female over 18, who consulted a homeopathic or non-
homeopathic GP for the ﬁrst time for symptoms of
anxiety disorders such as deﬁned by the DSM IV”. Strat-
egy H included 135 patients that received at least one
homeopathic drug and no psychotropic drugs, and strat-
egy P 185 patients that received at least one psychotropic
drug and no homeopathic drugs. In both strategies, other
drugs could have been prescribed (trace elements, etc).
Effectiveness was assessed by GPs using the “Hamilton
Anxiety Scale”, and by patients using the “Spielberger
State Trait Anxiety Inventory.” Satisfaction of GPs and
